ResQ Biotech
The startup operates a drug discovery platform that targets diseases linked to protein misfolding and aggregation, focusing on the identification and preclinical development of therapeutic molecules. This platform specifically addresses conditions such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis by enabling the development of treatments for misfolded soluble and integral membrane proteins.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$520KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a drug discovery platform that targets diseases linked to protein misfolding and aggregation, focusing on the identification and preclinical development of therapeutic molecules. This platform specifically addresses conditions such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis by enabling the development of treatments for misfolded soluble and integral membrane proteins.